Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.

Kotronen, Anna, Juurinen, Leena, Tiikkainen, Mirja, Vehkavaara, Satu, Yki–Järvinen, Hannele·2008·Gastroenterology
DOI 10.1053/j.gastro.2008.03.021

Cited by (339)

Items 301–339 of 339

  1. Combination antiretroviral therapy -associated lipodystrophy : insights into pathogenesis and treatment
    Ksenia Sevastianova · 2011 · Työväentutkimus Vuosikirja
  2. Insulin therapy in type 2 diabetes : Initiation, impact on liver fat, role of combination therapy with glitazones or glindes
    Leena Juurinen · 2014 · Työväentutkimus Vuosikirja
  3. Quantifier la stéatose hépatique, pourquoi ? comment ?
    Christophe Aubé · 2009 · Journal de Radiologie
  4. Family history of diabetes: a risk analysis
    Pedro André Mendes Mataloto · 2014 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
  5. Human adipose tissue morphology and function : relation to insulin sensitivity and glucose tolerance with focus on pregnancy and women with previous gestational diabetes mellitus
    Henrik G. Svensson · 2015 · Gothenburg University Publications Electronic Archive (Gothenburg University)
  6. with overfeeding in healthy young men combined composition during 14 days of step reduction Changes in insulin sensitivity precede changes in body
    Bente Klarlund Pedersen, Rikke Krogh‐Madsen, Carsten Eckhart Thomsen, Sine Haugaard Knudsen, Louise Seier Hansen, Maria Pedersen, Matthew James Laye, John P. Kirwan, Thomas P. J. Solomon, Steven K. Malin et al. · 2015
  7. pathogenesis of non-alcoholic fatty liver disease (NAFLD)
    Qing Liu, Stig Bengmark, Shen Qu · 2010
  8. On Glucose Metabolism in Patients with the m.3243A>G Mutation
    Markus M. Lindroos · 2013 · UTUPub (University of Turku)
  9. Is there a mechanistic link between hepatic steatosis and cardiac rather than liver events?
    Soo Kyung Lim · 2016
  10. Is insulin resistance the principal cause of NAFLD?
    Ian F. Godsland, Sanjeev Mehta, Shareen Forbes, Fabian Meienberg, Michael S. Yee, Simon David Taylor-Robinson, Desmond G. Johnston · 2016
  11. Impact of bariatric surgeries on diabetes outcomes
    Elza Muscelli, Hugo Muscelli Alecrim · 2014
  12. Peptide hydroxamate derivatives as regulators for insulin receptor signaling and its degradation by zinc metalloprotease in diabetic rats
    Mahmoud Elseweidy Mohamed, Rawia sarhan Amin, Hebatallah Husseini Atteia, Maha Abdo Ali, E Abo Dya Nader, Abdelazem Khaled · 2016 · African Journal of Pharmacy and Pharmacology
  13. ISCHEMIC HEART DISEASE; ASSOCIATION OF NON-ALCOHOLIC FATTY LIVER DISEASE
    Zaigham Rasool Khalid, Dr. Naseem Ahmed, Farhan Ali Rizvi, Mirza Ahmad Raza Baig · 2016 · The Professional Medical Journal
  14. with overfeeding in healthy young men composition during 14 days of step reduction combined Changes in insulin sensitivity precede changes in body
    Rikke Krogh‐Madsen, Carsten Eckhart Thomsen, Thomas P. J. Solomon, Bente Klarlund, Sine Haugaard Knudsen, Louise Seier Hansen, Maria Pedersen, Thomas Fremming Dejgaard · 2012
  15. Hormonal Responses that Regulate the Metabolic Benefits of Exercise: The Contribution of the Melanocortin System and the Fibroblast Growth Factor 21 (FGF21) Signaling Pathway
    Christine Loyd · 2014 · OhioLink ETD Center (Ohio Library and Information Network)
  16. Effects of LXRα phosphorylation on the regulation of lipid metabolism and hepatic fibrosis
    Natalia Bécares · 2017 · UCL Discovery (University College London)
  17. The Regulatory Effects of Trans-chalcone on Adipogenesis
    Younho Han · 2018 · International Journal of Oral Biology
  18. Response to Letter to the Editor: “Hepatic Insulin Extraction in NAFLD Is Related to Insulin Resistance Rather Than Liver Fat Content”
    Kristina M. Utzschneider, Steven E. Kahn, David Polidori · 2019 · The Journal of Clinical Endocrinology & Metabolism
  19. Efeito do treinamento físico na doença hepática gordurosa não alcoólica (DHGNA) em camundongos obesos: aspectos relacionados com a inflamação e resistência insulínica
    Lucas de Lucena Simões e Silva · 2020
  20. Fatty acid composition in four serum lipid fractions and the pathogenesis of diabetes
    Luke Johnston · 2017 · TSpace (University of Toronto)
  21. Immune dysregulation in nonalcoholic steatohepatitis
    Ankita Chatterjee, Priyadarshi Basu · 2022 · Elsevier eBooks
  22. Pathogenesis
    Mark Walker, Xuefei Yu, Amalia Gastaldelli · 2022
  23. Exercise and training in NAFLD and insulin resistance
    Bram Brouwers · 2016
  24. Avaliação do efeito dos leucotrienos e do sistema renina-angiotensina em órgãosmetabolicamente ativos de camundongos com diabetes do tipo 1 e obesidade
    João Pedro Tôrres Guimarães · 2021 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  25. Predictors of hepatic steatosis in living liver donors
    Marina Gennadievna Minina, D. V. Voronov, A. A. Nevredimov, E. A. Tenchurina · 2022 · Russian Journal of Transplantology and Artificial Organs
  26. Evaluation of Biochemical Changes in Induced Diabetic Male Rats by Different Methods.
    Omnia khaled Metwally, Amira Mersal, Ahkam M. El-Gendy, Nageh Mabrouk Gabr · 2023 · International Journal of Theoretical and Applied Research
  27. Simplified Protocol for Production of Persistent Hyperglycemic Zebrafish Model for Type II Diabetes Mellitus Studying
    Khaled Mohammed-Geba · 2024 · Egyptian Journal of Aquatic Biology and Fisheries
  28. Macronutrient Intake and Disease: A Focus on Diabetes
    Mahdiyeh Kooshki, Vahid Reza Askari, Vafa Baradaran Rahimi · 2025 · Springer eBooks
  29. Adipose Tissue Insulin Sensitivity, Adipocyte Function, and Regulation of Systemic Metabolism
    Tetsuya Hosooka · 2025 · Nippon Eiyo Shokuryo Gakkaishi
  30. Low Hepatic CEACAM1 Tethers Metabolic Dysfunction Steatohepatitis to Atherosclerosis
    Sacha El Khoury, Sami N. Al Harake, Tya Youssef, Carl E. Risk, Naim G. Helou, Natalie M. Doumet, K. Aramouni, Sami Azar, Sonia M. Najjar, Hilda E. Ghadieh · 2025 · Livers
  31. Late start of eating is linked to hyperinsulinemia, insulin resistance, and increased body fat in prediabetes
    Beeke Peters, Noelle Froehlich, J Machann, Ulrike Dambeck, Caroline Honsek, Christiana Gerbracht, Anna Sachno, Margrit Kemper, Stefan Kabisch, Andreas Fritsche et al. · 2026 · medRxiv
  32. Emerging therapeutic approaches in neurobiology of type 2 diabetes
    Umesh Kumar, Sakshi Garg, Aditya Shrivastav, Bhaskar Sharma, Bhumi Arora, Bhupender Sahu, Manisha Gupta · 2026 · Elsevier eBooks
  33. Personalized Medicine Approaches in Metabolically Associated Fatty Liver Disease: A Comprehensive Review
    Vaibhavkumar Patel, Archana Mohit Navale, Pratichi Singh · 2026 · SN Comprehensive Clinical Medicine
  34. Marqueurs non-invasifs de stéatose et fibrose hépatique
    Hugo Perazzo · 2014 · theses.fr (ABES)
  35. La nécroptose : une nouvelle cible thérapeutique dans la stéatohépatite non-alcoolique
    Amine Majdi · 2020
  36. Identification of candidate biomarkers for NAFLD through bioinformatics analysis and machine learning based on circulating insulin degradation-associated genes
    Mingjie Guo, Wei Lou, Xin Song, Dong-Xin Gao, Guo'an Wang, Hanyu Ma, Wenlei Wang, Yong-Liang Wang · 2026 · Frontiers in Endocrinology
  37. The efficacy of carbohydrate-restricted diets on reducing visceral and liver fat in individuals with overweight and obesity: a systematic review and pairwise and network meta-analyses
    Mousa Khalafi, Aref Habibi Maleki, Mahsa Ehsanifar, Maryam Aghaeinejad, Mohammad Hossein Sakhaei, Sara K. Rosenkranz, Michael E. Symonds, Fatemeh Ramezani · 2026 · Critical Reviews in Food Science and Nutrition
  38. High Basal Skeletal Muscle Glucose Uptake in Normoglycemic and Hyperinsulinemic Overweight Men Is Coupled With an Increase in Alanine-Glucose Cycling
    Laura Hjort Blicher, Leanne Hodson, Kieran Smith, B. Hald, Birgitte Andersen, Fredrik Karpe · 2026 · Diabetes
  39. Insulin resistance, not hepatic histological features, is the dominant correlate of insulin clearance in class 3 obesity
    Aika Miya, Andrea Tura, Anita Shokouhmehr, Irene Esposito, Aslihan Yavas, Frank Alexander Granderath, Matthias Schlensak, Maximilian Huttasch, Georgia Xourafa, Geronimo Heilmann et al. · 2026 · Diabetes Research and Clinical Practice